GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,279.00
Bid: 1,283.00
Ask: 1,285.00
Change: -35.00 (-2.66%)
Spread: 2.00 (0.156%)
Open: 1,311.00
High: 1,314.00
Low: 1,266.00
Prev. Close: 1,314.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Indivior chief HR officer sells; Volex COO buys

Tue, 15th Mar 2022 16:49

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

Indivior PLC - North Chesterfield, Virginia-based treatments for opioid addiction - Chief Human Resources Officer Jon Fogle sells 157,844 shares at GBP2.71, worth GBP427,757, on Monday. Fogle still has 301,732 shares.

----------

Volex PLC - Hampshire, England-based Volex electronic components maker - Sharon Molloy, wife of Chief Operating Officer John Molloy, buys 95,000 shares at average 261.98p, worth GBP248,883, on Monday. The Molloys now have 2.3 million shares, a 1.5% stake.

----------

Supermarket Income REIT PLC - real estate investment trust investing in supermarket property - Steven Noble, chief investment officer of investment adviser Atrato Capital Ltd, buys 156,705 shares at 121.18p, worth GBP189,895, on Monday.

----------

Croda International PLC - Yorkshire, England-based chemicals maker - Croda corrects that Sarah Brophy, an associate of General Counsel Tom Brophy, bought, rather than sold, 1,401 shares at GBP70.99 each, worth GBP99,457, on March 10.

----------

Chemring Group PLC - Romsey, Hampshire-based defence technology - Karen Lewis, wife of Finance Director Andrew Lewis, sells 18,000 shares at 333.94 pence, worth GBP60,109, on Monday. Andrew Lewis remains interested in 231,272 shares.

----------

Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Chief Financial Officer James McCarthy buys 39,670 shares at average GBP2.02, worth GBP80,133, on Monday. Now has 49,670 shares.

----------

AJ Bell PLC - Manchester-based retail investment platform - Investments Managing Director Kevin Doran buys 32,259 shares at GBP3.10, worth GBP100,000, on Tuesday. Now has 244,365 shares.

----------

AB Dynamics PLC - Bradford On Avon, Wiltshire-based testing systems and measurement products for automotive market - Mark Allman, managing director of Anthony Best Dynamics Ltd, buys 5,272 shares at 1,100 pence, worth GBP57,992, on Thursday last week. The purchase is his only holding.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
16 Feb 2022 09:16

TOP NEWS: Indivior swings to profit in 2021; mulling US listing

(Alliance News) - Indivior PLC shares jumped on Wednesday after it reported a swing to profit in 2021 and annual revenue moved closer to its eventual target of USD1 billion.

Read more
16 Feb 2022 09:00

LONDON MARKET OPEN: Geopolitical tensions calm but inflation in focus

(Alliance News) - London's FTSE 100 stock index edged cautiously higher in early dealings on Wednesday, with a seeming de-escalation by Russia of its threat to Ukraine lifting the mood, though traders were wary about a backdrop of inflationary pressures in both the UK and US.

Read more
16 Feb 2022 07:49

LONDON MARKET PRE-OPEN: Franchise Brands buys fellow AIM firm Filta

(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.

Read more
16 Feb 2022 07:05

Indivior considers US listing after returning to profit

(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.

Read more
9 Feb 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
28 Jan 2022 16:22

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

Read more
28 Jan 2022 14:53

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Read more
28 Jan 2022 09:02

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Read more
28 Jan 2022 07:55

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
10 Nov 2021 12:28

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

Read more
10 Nov 2021 10:12

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Read more
10 Nov 2021 08:07

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
28 Oct 2021 13:23

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.